Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; “Real Time” Surveys of Consumers' Knowledge, Perceptions, and Reported Behavior Concerning Foodborne Illness Outbreaks or Food Recalls, 23773-23775 [2010-10357]
Download as PDF
23773
Federal Register / Vol. 75, No. 85 / Tuesday, May 4, 2010 / Notices
(MCHB), which is implementing the
Combating Autism Act Initiative (CAAI)
in response to the legislative mandate.
The purpose of this evaluation is to
design and implement a three-year
assessment of the effectiveness of
MCHB’s activities in meeting the goals
and objectives of the CAAI, and to
provide sufficient data to inform MCHB
and the Congress as to the utility of the
grant programs funded under the
Initiative. To address the requirements
for the Report to Congress, the
evaluation will focus on short-term
indicators related to: (1) Increasing
awareness of ASD and other DD among
health care providers, other MCH
professionals and the general public; (2)
reducing barriers to screening and
diagnosis; (3) supporting research on
evidence-based interventions; (4)
promoting the development of evidencebased guidelines and tested/validated
intervention tools; and (5) training
professionals.
Respondents: Grantees funded by
HRSA under the CAAI will be the
respondents for this data collection
activity. The programs to be evaluated
are listed below.
1. Training Programs
• Leadership Education in
Neurodevelopmental Disabilities
(LEND) training programs with thirty
nine grantees; and
• Developmental Behavioral
Pediatrics (DBP) training programs with
six grantees.
2. Research Programs
• Two Autism Intervention Research
Networks that focus on intervention
research, guideline development, and
information dissemination;
• Five R40 Maternal and Child Health
(MCH) Autism Intervention Research
Program grantees that support research
on evidence-based practices for
interventions to improve the health and
well-being of children and adolescents
with ASD and other DD; and
• Two R40 MCH Autism Intervention
Secondary Data Analysis Study (SDAS)
Program grantees that support research
on evidence-based practices for
interventions to improve the health and
well-being of children and adolescents
with ASD and other DD, utilizing
exclusively the analysis of existing
secondary data.
3. State Implementation Program Grants
for Improving Services for Children and
Youth With Autism Spectrum Disorder
(ASD) and Other Developmental
Disabilities (DD)
• Nine grantees will implement state
autism plans and develop models for
improving the system of care for
children and youth with ASD and other
DD.
The data gathered through this
evaluation will be used to:
• Evaluate the grantees’ performance
in achieving the objectives of the CAAI
during the three year grant period;
• Assess the short- and intermediateterm impacts of the grant programs on
children and
• families affected by ASD and other
DD;
• Measure the CAAI outputs and
outcomes for the Report to Congress;
and
• Provide foundation data for future
measurement of the initiative’s longterm impact.
The estimated response burden is
shown in Table 1.
TABLE 1—ESTIMATED HOUR AND COST BURDEN OF THE DATA COLLECTION
No. of
respondents
Responses
per
respondent
LEND ........................................................
DBP ..........................................................
State Implementation Program ................
Research Program ...................................
39
6
9
9
6
6
6
6
234
36
54
54
.75
.75
.75
.75
175.5
27
40.5
40.5
$39.36
39.36
38.22
39.36
$6907.68
1062.72
1547.91
1594.08
Total ..................................................
63
....................
378
....................
283.5
....................
11,112.39
Grant program
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov
or by fax to 202–395–6974. Please direct
all correspondence to the ‘‘attention of
the desk officer for HRSA.’’
Dated April 28, 2010.
Sahira Rafiullah,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2010–10450 Filed 5–3–10; 8:45 am]
mstockstill on DSKH9S0YB1PROD with NOTICES
BILLING CODE 4165–15–P
Average
hours per
response
Total responses
Food and Drug Administration
DATES: Fax written comments on the
collection of information by June 3,
2010.
[Docket No. FDA–2009–N–0535]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; ‘‘Real Time’’
Surveys of Consumers’ Knowledge,
Perceptions, and Reported Behavior
Concerning Foodborne Illness
Outbreaks or Food Recalls
AGENCY:
Food and Drug Administration,
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
Jkt 220001
Total hour
cost
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
ACTION:
18:58 May 03, 2010
Wage rate
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
HHS.
VerDate Mar<15>2010
Total hour
burden
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or e-mailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–NEW and
title ‘‘‘Real Time’ Surveys of Consumers’
Knowledge, Perceptions, and Reported
Behavior Concerning Foodborne Illness
Outbreaks or Food Recalls.’’ Also
include the FDA docket number found
in brackets in the heading of this
document.
E:\FR\FM\04MYN1.SGM
04MYN1
23774
Federal Register / Vol. 75, No. 85 / Tuesday, May 4, 2010 / Notices
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
3793.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
‘‘Real Time’’ Surveys of Consumers’
Knowledge, Perceptions, and Reported
Behavior Concerning Foodborne Illness
Outbreaks or Food Recalls ( OMB
Control No. 0910–NEW)
I. Description
FDA communicates with consumers
about food recalls directly, at its own
Web site, and through various mass
media channels, such as television and
newspapers, during a foodborne illness
outbreak or food recall. In these
communications, FDA typically
identifies the implicated food, the
symptoms of the foodborne illness at
issue, any subpopulations at elevated
risk of infection or illness, and
protective measures individuals can or
should take. The purpose of these
communications is to provide
consumers with information so they can
protect themselves from potential health
risks associated with an outbreak or
food recall. Consumers also get
information about an outbreak or recall
from other sources, including other
Federal and State agencies, industry,
consumer groups, and the mass media,
which may or may not relay FDA’s
public announcements.
Existing data show that many
consumers do not take appropriate
protective actions during a foodborne
illness outbreak or food recall (Refs. 1
and 2). For example, 41 percent of U.S.
consumers say they have never looked
for any recalled product in their home
(Ref. 2). Conversely, some consumers
overreact to the announcement of a
foodborne illness outbreak or food
recall. In response to the 2006 fresh,
bagged spinach recall which followed a
multistate outbreak of E. coli O157: H7
infections (Ref. 3), 18 percent of
consumers said they stopped buying
other bagged, fresh produce because of
the spinach recall (Ref. 1). Existing
research also suggests that many
consumers may not have correct
knowledge about products subject to a
given recall. For example, in a survey
conducted 2 months after the onset of
the 2006 spinach recall, one third of
respondents did not know that, in
addition to bagged spinach, fresh loose
spinach was part of the recall, while 22
percent believed that frozen spinach
was subject to the recall (it was not)
(Refs. 1 and 3). In order for FDA to
protect the public health during
foodborne illness outbreaks or food
recalls, the Agency needs timely
information collected from consumers
as the events unfold to ensure that
consumers understand the extent of the
incident and that they are taking
appropriate actions. Results from the
information collection will indicate to
FDA whether the Agency should adjust
its communications to help consumers
react appropriately.
FDA conducts research and
educational and public information
programs relating to food safety under
its broad statutory authority, set forth in
section 903(b)(2) of the Federal Food,
Drug, and Cosmetic Act (the act) (21
U.S.C. 393 (b)(2), to protect the public
health by ensuring that foods are ‘‘safe,
wholesome, sanitary, and properly
labeled,’’ and in section 903(d)(2)(C) to
conduct research relating to foods,
drugs, cosmetics, and devices in
carrying out the act.
FDA plans to survey U.S. consumers
using a Web-based panel of U.S.
households to collect information on
consumers’ ‘‘real time’’ knowledge,
perceptions, beliefs, and self-reported
behaviors for up to five foodborne
illness outbreaks or food recalls a year.
Moreover, because the information
environment during certain foodborne
illness outbreaks or food recalls evolves
as new information emerges, the Agency
plans to field up to three waves of
independent surveys per event (i.e.,
outbreak or recall). The surveys will
query consumers on topics such as: (1)
The products that are subject to the
outbreak or recall, (2) the implicated
pathogens, (3) the food vehicle of the
outbreak or recall, and (4) how
consumers can protect themselves. FDA
plans to conduct the surveys soon after
the onset of an outbreak or recall and
whenever the Agency suspects that: (1)
Messages are not reaching consumers,
and/or (2) consumers do not understand
the messages, and/or (3) consumers are
not taking appropriate actions in
response to the messaging. Collecting
information quickly during a foodborne
illness outbreak or food recall is
important because erroneous
perceptions or misinterpreted
information about an outbreak or recall
can impede consumer adoption of
recommended protective behaviors.
Criteria for selecting a particular
foodborne illness outbreak or food recall
for a survey will include a qualitative
assessment of the salience of some or all
of the following: The geographical
dispersion of the event, the number of
illnesses or deaths associated with it,
the relative familiarity of the food
product, the complexity of consumer
precaution instructions, and the
presence of national media focus.
The Agency will use the survey
results to help adjust its communication
strategies and messages for foodborne
illness outbreaks or food recalls, when
needed. The results will not be used to
develop population estimates.
In the Federal Register of November
18, 2009 (74 FR 59558), FDA published
a 60-day notice requesting public
comment on the proposed collection of
information. No comments were
received.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1
Activity
No. of
Respondents
Screener
Total Annual
Responses
Hours per Response
1
30,000
.0055
165
40
1
40
.167
7
15,000
Survey
1
15,000
.167
2,505
Total
1 There
Total Hours
30,000
Pre-test
mstockstill on DSKH9S0YB1PROD with NOTICES
Annual Frequency
per Response
2,677
are no capital costs or operating and maintenance costs associated with this collection of information.
VerDate Mar<15>2010
18:58 May 03, 2010
Jkt 220001
PO 00000
Frm 00111
Fmt 4703
Sfmt 4703
E:\FR\FM\04MYN1.SGM
04MYN1
Federal Register / Vol. 75, No. 85 / Tuesday, May 4, 2010 / Notices
Approximately 30,000 respondents of
a Web-based consumer panel will be
screened (3 waves (independent
surveys)) for each of 5 incidents; 2,000
respondents per wave). We estimate that
it will take a respondent 20 seconds
(0.0055 hours) to complete the screening
questions, for a total of 165 hours. We
will conduct a pre-test of the first survey
with 40 respondents; we estimate that it
will take a respondent 10 minutes
(0.167 hours) to complete the pre-test,
for a total of 7 hours. Fifteen thousand
(15,000) respondents will complete the
surveys (3 waves (independent surveys))
for each of 5 incidents; 1,000
respondents per wave). We estimate that
it will take a respondent 10 minutes
(0.167 hours) to complete the survey, for
a total of 2,505 hours. Thus, the total
estimated burden is 2,677 hours. FDA’s
burden estimate is based on prior
experience with consumer surveys that
are similar to these.
II. References
1. Cuite, C., S. Condry, M. Nucci, et al.,
‘‘Public Response to the Contaminated
Spinach Recall of 2006,’’ Publication no. RR–
0107–013, New Brunswick, NJ: Rutgers, the
State University of New Jersey, Food Policy
Institute, 2007.
2. Hallman, W., C. Cuite, N. Hooker,
‘‘Consumer Responses to Food Recalls: 2009
National Survey Report,’’ Publication no. RR–
0109–018, New Brunswick, NJ: Rutgers, the
State University of New Jersey, Food Policy
Institute, 2009.
3. Acheson, D., ‘‘Outbreak of Escherichia
coli 0157 Infections Associated With Fresh
Spinach—United States, August-September
2006,’’ 2007 (https://first.fda.gov/cafdas/
documents/Acheson_Spinach_
Outbreak_2006_FDA_pres.ppt).
Dated: April 28, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–10357 Filed 5–3–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
mstockstill on DSKH9S0YB1PROD with NOTICES
[Docket No. FDA–2010–N–0184]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Experimental
Study of Patient Information
Prototypes
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
SUMMARY:
VerDate Mar<15>2010
18:58 May 03, 2010
Jkt 220001
proposed collection of certain
information by the agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments for
research entitled ‘‘Experimental Study of
Patient Information Prototypes.’’ This
study is designed to determine based on
different prototype testing whether
consumers are able to comprehend
serious warnings, directions for use,
drug indications and uses,
contraindications, and side effects in the
material that is presented.
DATES: Submit written or electronic
comments on the collection of
information by July 6, 2010.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Berbakos, Office of
Management Programs (HFA–250), Food
and Drug Administration, 1350 Piccard
Dr., PI50–400B, Rockville, MD 20850
301–796–3792,
Elizabeth.Berbakos@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
Under the PRA (44 U.S.C. 3501–
3520), Federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined in
44 U.S.C. 3502(3) and 5 CFR 1320.3(c)
and includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2) (A)) requires Federal agencies
to provide a 60-day notice in the
Federal Register concerning each
proposed collection of information
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) whether
the proposed collection of information
PO 00000
Frm 00112
Fmt 4703
Sfmt 4703
23775
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Experimental Study of Patient
Information Prototypes—New
In order to make informed decisions
about health care and to use their
medications correctly, consumers need
easy access to up-to-date and accurate
information about the risks, benefits and
safe use of their prescription drugs.
Consumers currently receive multiple
pieces of paper with their prescription
drugs from the pharmacy, containing
information that is developed and
distributed through various sources.
Written prescription drug information is
provided through a voluntary effort
(Consumer Medication Information)1 as
well as through FDA mandated use of
Medication Guides2 and Patient Package
Inserts (PPI).3 Patients describe a wide
range of experiences and varying
degrees of satisfaction with information
currently provided at the time
medicines are received at the pharmacy.
In some cases, the written documents
are difficult to read and understand,
duplicative and overlapping,
incomplete or contradictory. FDA has
held multiple public meetings to solicit
feedback on providing balanced,
comprehensive and up-to-date
prescription drug information to
consumers.
Since 1968, FDA regulations have
required that PPIs written specifically
for patients be distributed when certain
prescription drugs or classes of
prescription drugs are dispensed. PPIs
are required for estrogens and oral
contraceptives, are considered part of
the product labeling, and are to be
dispensed to the patient with the
product. In the 1970s, FDA began
evaluating the general usefulness of
patient labeling for prescription drugs
resulting in a series of regulatory steps
to help ensure the availability of useful
written consumer information. Other
1 Public Law 104–180, August 6, 1996, Title VI.
Effective Medication Guides.
2 21 CFR part 208.
3 21 CFR 310.501 and 310.515.
E:\FR\FM\04MYN1.SGM
04MYN1
Agencies
[Federal Register Volume 75, Number 85 (Tuesday, May 4, 2010)]
[Notices]
[Pages 23773-23775]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-10357]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0535]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; ``Real Time'' Surveys
of Consumers' Knowledge, Perceptions, and Reported Behavior Concerning
Foodborne Illness Outbreaks or Food Recalls
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by June 3,
2010.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or e-mailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-NEW and
title ```Real Time' Surveys of Consumers' Knowledge, Perceptions, and
Reported Behavior Concerning Foodborne Illness Outbreaks or Food
Recalls.'' Also include the FDA docket number found in brackets in the
heading of this document.
[[Page 23774]]
FOR FURTHER INFORMATION CONTACT: Denver Presley, Office of Information
Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B,
Rockville, MD 20850, 301-796-3793.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
``Real Time'' Surveys of Consumers' Knowledge, Perceptions, and
Reported Behavior Concerning Foodborne Illness Outbreaks or Food
Recalls ( OMB Control No. 0910-NEW)
I. Description
FDA communicates with consumers about food recalls directly, at its
own Web site, and through various mass media channels, such as
television and newspapers, during a foodborne illness outbreak or food
recall. In these communications, FDA typically identifies the
implicated food, the symptoms of the foodborne illness at issue, any
subpopulations at elevated risk of infection or illness, and protective
measures individuals can or should take. The purpose of these
communications is to provide consumers with information so they can
protect themselves from potential health risks associated with an
outbreak or food recall. Consumers also get information about an
outbreak or recall from other sources, including other Federal and
State agencies, industry, consumer groups, and the mass media, which
may or may not relay FDA's public announcements.
Existing data show that many consumers do not take appropriate
protective actions during a foodborne illness outbreak or food recall
(Refs. 1 and 2). For example, 41 percent of U.S. consumers say they
have never looked for any recalled product in their home (Ref. 2).
Conversely, some consumers overreact to the announcement of a foodborne
illness outbreak or food recall. In response to the 2006 fresh, bagged
spinach recall which followed a multistate outbreak of E. coli O157: H7
infections (Ref. 3), 18 percent of consumers said they stopped buying
other bagged, fresh produce because of the spinach recall (Ref. 1).
Existing research also suggests that many consumers may not have
correct knowledge about products subject to a given recall. For
example, in a survey conducted 2 months after the onset of the 2006
spinach recall, one third of respondents did not know that, in addition
to bagged spinach, fresh loose spinach was part of the recall, while 22
percent believed that frozen spinach was subject to the recall (it was
not) (Refs. 1 and 3). In order for FDA to protect the public health
during foodborne illness outbreaks or food recalls, the Agency needs
timely information collected from consumers as the events unfold to
ensure that consumers understand the extent of the incident and that
they are taking appropriate actions. Results from the information
collection will indicate to FDA whether the Agency should adjust its
communications to help consumers react appropriately.
FDA conducts research and educational and public information
programs relating to food safety under its broad statutory authority,
set forth in section 903(b)(2) of the Federal Food, Drug, and Cosmetic
Act (the act) (21 U.S.C. 393 (b)(2), to protect the public health by
ensuring that foods are ``safe, wholesome, sanitary, and properly
labeled,'' and in section 903(d)(2)(C) to conduct research relating to
foods, drugs, cosmetics, and devices in carrying out the act.
FDA plans to survey U.S. consumers using a Web-based panel of U.S.
households to collect information on consumers' ``real time''
knowledge, perceptions, beliefs, and self-reported behaviors for up to
five foodborne illness outbreaks or food recalls a year. Moreover,
because the information environment during certain foodborne illness
outbreaks or food recalls evolves as new information emerges, the
Agency plans to field up to three waves of independent surveys per
event (i.e., outbreak or recall). The surveys will query consumers on
topics such as: (1) The products that are subject to the outbreak or
recall, (2) the implicated pathogens, (3) the food vehicle of the
outbreak or recall, and (4) how consumers can protect themselves. FDA
plans to conduct the surveys soon after the onset of an outbreak or
recall and whenever the Agency suspects that: (1) Messages are not
reaching consumers, and/or (2) consumers do not understand the
messages, and/or (3) consumers are not taking appropriate actions in
response to the messaging. Collecting information quickly during a
foodborne illness outbreak or food recall is important because
erroneous perceptions or misinterpreted information about an outbreak
or recall can impede consumer adoption of recommended protective
behaviors. Criteria for selecting a particular foodborne illness
outbreak or food recall for a survey will include a qualitative
assessment of the salience of some or all of the following: The
geographical dispersion of the event, the number of illnesses or deaths
associated with it, the relative familiarity of the food product, the
complexity of consumer precaution instructions, and the presence of
national media focus.
The Agency will use the survey results to help adjust its
communication strategies and messages for foodborne illness outbreaks
or food recalls, when needed. The results will not be used to develop
population estimates.
In the Federal Register of November 18, 2009 (74 FR 59558), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received.
FDA estimates the burden of this collection of information as
follows:
Table 1.--Estimated Annual Reporting Burden\1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
No. of Annual Frequency Total Annual
Activity Respondents per Response Responses Hours per Response Total Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Screener 30,000 1 30,000 .0055 165
--------------------------------------------------------------------------------------------------------------------------------------------------------
Pre-test 40 1 40 .167 7
--------------------------------------------------------------------------------------------------------------------------------------------------------
Survey 15,000 1 15,000 .167 2,505
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total ................. .................... .................... .................... 2,677
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
[[Page 23775]]
Approximately 30,000 respondents of a Web-based consumer panel will
be screened (3 waves (independent surveys)) for each of 5 incidents;
2,000 respondents per wave). We estimate that it will take a respondent
20 seconds (0.0055 hours) to complete the screening questions, for a
total of 165 hours. We will conduct a pre-test of the first survey with
40 respondents; we estimate that it will take a respondent 10 minutes
(0.167 hours) to complete the pre-test, for a total of 7 hours. Fifteen
thousand (15,000) respondents will complete the surveys (3 waves
(independent surveys)) for each of 5 incidents; 1,000 respondents per
wave). We estimate that it will take a respondent 10 minutes (0.167
hours) to complete the survey, for a total of 2,505 hours. Thus, the
total estimated burden is 2,677 hours. FDA's burden estimate is based
on prior experience with consumer surveys that are similar to these.
II. References
1. Cuite, C., S. Condry, M. Nucci, et al., ``Public Response to
the Contaminated Spinach Recall of 2006,'' Publication no. RR-0107-
013, New Brunswick, NJ: Rutgers, the State University of New Jersey,
Food Policy Institute, 2007.
2. Hallman, W., C. Cuite, N. Hooker, ``Consumer Responses to
Food Recalls: 2009 National Survey Report,'' Publication no. RR-
0109-018, New Brunswick, NJ: Rutgers, the State University of New
Jersey, Food Policy Institute, 2009.
3. Acheson, D., ``Outbreak of Escherichia coli 0157 Infections
Associated With Fresh Spinach--United States, August-September
2006,'' 2007 (https://first.fda.gov/cafdas/documents/Acheson_Spinach_Outbreak_2006_FDA_pres.ppt).
Dated: April 28, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-10357 Filed 5-3-10; 8:45 am]
BILLING CODE 4160-01-S